ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Inferior Vena Cava Filters (IVCF) Market, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1532797
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 301 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,475,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,403,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,781,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå ±Ô¸ð´Â 2023³â 8¾ï 109¸¸ ´Þ·¯·Î 2024-2032³â ¿¬Æò±Õ 8.90%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå - ½ÃÀå ¿ªÇÐ

Á¤¸ÆÇ÷Àü»öÀüÁõ(VTE)ÀÇ À¯º´·ü Áõ°¡¿Í IVCF ±â¼úÀÇ ¹ßÀüÀ¸·Î ½ÃÀå ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»ó

½ÉºÎÁ¤¸ÆÇ÷ÀüÁõ(DVT)°ú Æó»öÀüÁõ(PE)À» Æ÷ÇÔÇÑ Á¤¸ÆÇ÷Àü»öÀüÁõ(VTE)Àº Àü ¼¼°èÀûÀ¸·Î ¼ö¹é¸¸ ¸íÀÌ ¾Î°í ÀÖ´Â ½É°¢ÇÑ ÁúȯÀ¸·Î IVCF¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, IVCF´Â DVT ȯÀÚ Áß °íÀ§Ç豺 ¹× Ç×ÀÀ°íÁ¦ »ç¿ëÀÌ ±Ý±âÀΠȯÀÚÀÇ PE¸¦ ¿¹¹æÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÕ´Ï´Ù. Áß¿äÇÕ´Ï´Ù. ƯÈ÷ ÇÏÁö ¹× °ñ¹Ý°ú °ü·ÃµÈ ¼ö¼úÀÌ º¸ÆíÈ­µÊ¿¡ µû¶ó DVT¿Í ±×¿¡ µû¸¥ PEÀÇ À§ÇèÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, IVCF´Â ÀÌ·¯ÇÑ °æ¿ìÀÇ ¿¹¹æÃ¥ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀ¸·Î IVCFÀÇ µðÀÚÀΰú È¿°ú°¡ °³¼±µÇ¾î ´õ¿í ¾ÈÀüÇϰí È¿°úÀûÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¿©±â¿¡´Â »ýü ÀûÇÕ¼º Çձݰú °°Àº ±¸Á¶¿¡ »ç¿ëµÇ´Â Àç·á¿Í À̵¿ ¶Ç´Â ÆÄ¼ÕÀÇ À§ÇèÀ» ÁÙÀÌ´Â ¼³°è°¡ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ, VTEÀÇ À§Çè°ú IVCFÀÇ ÀûÀýÇÑ »ç¿ë¿¡ ´ëÇÑ ÀÇ·áÁøÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ IVCFÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áø´Ü ±â¼úÀÇ ¹ßÀüÀ¸·Î DVT¸¦ ½±°Ô ¹ß°ßÇÒ ¼ö ÀÖ°Ô µÇ¸é¼­ ¿¹¹æÀû Á¶Ä¡·Î IVCF¸¦ »ç¿ëÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó ¼ºÀå°ú ÀÇ·áºñ Áõ°¡·Î ÀÎÇØ IVCF ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¸Å³â ¾à 8.90%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç° À¯Çüº°·Î´Â ³ôÀº ³»±¸¼º°ú Àå±âÀûÀÎ ½ºÀ§ÄªÀÇ ÀåÁ¡À¸·Î ÀÎÇØ ¿µ±¸ ºÎ¹®ÀÌ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµÆ½À´Ï´Ù.

¿ëµµº°·Î´Â Á¤¸ÆÇ÷Àü»öÀüÁõ ºÎ¹®ÀÌ 2023³â ÃÖ¼Òħ½ÀÀû ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÁÖ¿ä ÀÀ¿ë ºÐ¾ß·Î ºÎ»óÇß½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â Á¤¸ÆÇ÷Àü»öÀüÁõ ÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ º´¿ø ºÎ¹®ÀÌ 2023³â ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚ·Î ºÎ»óÇß½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ VTE ȯÀÚ ¼ö°¡ ¸¹¾Æ 2023³â ¸ÅÃâÀ» ÁÖµµÇß½À´Ï´Ù.

ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ¼¼°è ½ÃÀåÀº Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó ȸ¼öÇü°ú ¿µ±¸Çü µÎ °¡Áö·Î ³ª´¹´Ï´Ù. ¿µ±¸Çü ºÎ¹®ÀÌ ½ÃÀåÀ» Áö¹èÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ º´¿ø¿¡¼­ ¿µ±¸Çü IVCFÀÇ ³ôÀº äÅ÷üÀÌ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ¿ëµµ¿¡ µû¶ó Á¤¸ÆÇ÷Àü»öÀüÁõ°ú Æó»öÀüÁõÀ¸·Î ³ª´¹´Ï´Ù. Á¤¸ÆÇ÷Àü»öÀüÁõ ºÎ¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ½ÉÀå Áúȯ ¹× ±âŸ Æó ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾»ç¿ëÀÚº°·Î º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ±âŸ ¼¼ °¡Áö·Î ºÐ·ùµË´Ï´Ù. º´¿ø ºÎ¹®ÀÌ ½ÃÀåÀ» Áö¹èÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È ³ôÀº ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÉÀå Áúȯ ¹× Ç÷¾× ÀÀ°í Àå¾Ö·Î ÀÎÇÑ Ä¡·á¿¡ ´ëÇÑ º´¿øÀÇ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Àü ¼¼°èÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì¿¡¼­ ¹Ì±¹°ú ij³ª´Ù´Â ÀÇ·á ½Ã½ºÅÛÀÌ Àß È®¸³µÇ¾î ÀÖ°í VTE¿Í ±× ÇÕº´Áõ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô½À´Ï´Ù. ÀÌ ½ÃÀåÀ» ÁÖµµÇÏ´Â °ÍÀº ȯÀÚ ¼ö, ÷´Ü ÀÇ·á ±â¼ú ¹× À¯¸®ÇÑ »óȯ Á¤Ã¥ÀÔ´Ï´Ù. ȸ¼ö °¡´ÉÇÑ IVCF¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä´Â PE À§ÇèÀÌ °¨¼ÒÇϸé Á¦°ÅÇÒ ¼ö ÀÖ´Â Àӽà ÇÊÅÍ¿¡ ´ëÇÑ ¼±È£µµ¸¦ ¹Ý¿µÇÕ´Ï´Ù. À¯·´¿¡¼­´Â ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ÀÇ·á ½Ã¼³ÀÇ °³¼±ÀÌ IVCFÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå - °æÀï »óȲ:

ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀåÀº ÀÌ·¯ÇÑ ÀÇ·á±â±â¸¦ Çõ½Å, Á¦Á¶ ¹× ÆÇ¸ÅÇÏ´Â ¿©·¯ ÁÖ¿ä ±â¾÷µéÀÌ Ä¡¿­ÇÏ°Ô °æÀïÇϸç ÁÖµµÇϰí ÀÖÀ¸¸ç, IVCF ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ Áß ÇϳªÀÎ Boston ScientificÀº ´Ù¾çÇÑ IVCF Á¦Ç°À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÀå ¾÷üµéÀº Á¦Ç°ÀÇ µðÀÚÀÎ, È¿´É ¹× ¾ÈÀü¼ºÀ» °³¼±Çϱâ À§ÇØ ¿¬±¸ °³¹ß¿¡ Áö¼ÓÀûÀ¸·Î ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ±â¼úÀû Áøº¸¿¡´Â ÀüÀÌ ¹× ÆÄ¼Õ°ú °°Àº ÇÕº´ÁõÀ» ÁÙÀ̱â À§ÇÑ °­È­µÈ ÇÊÅÍ ¼³°è¿Í »ýüÀûÇÕ¼ºÀ» Çâ»ó½ÃŰ´Â Àç·á µîÀÌ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF)ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ¾÷°è Á¶»ç

Á¦5Àå ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå »óȲ

Á¦7Àå ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå - Á¦Ç° À¯Çüº°

Á¦8Àå ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå - ¿ëµµº°

Á¦9Àå ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÇÏ´ëÁ¤¸Æ ÇÊÅÍ(IVCF) ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Inferior Vena Cava Filters (IVCF) Market size was valued at USD 801.09 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

Inferior Vena Cava Filters (IVCF) are medical devices designed to prevent blood clots from reaching the lungs. They are placed inside the inferior vena cava, which is the large vein that carries deoxygenated blood from the lower half of the body to the heart.

Inferior Vena Cava Filters (IVCF) Market- Market Dynamics

Growing prevalence of Venous Thromboembolism (VTE) and advancement in IVCF technology are expected to propel market demand

Venous Thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant medical condition affecting millions worldwide, which is boosting the demand for IVCFs. IVCFs are crucial for preventing PE in patients with DVT who are at high risk or have contraindications to anticoagulant therapy. As surgical procedures become more common, particularly those involving the lower extremities and pelvis, the risk of DVT and subsequent PE rises. IVCFs provide a preventive measure in such cases.

Technological advancements have improved the design and efficacy of IVCFs, making them safer and more effective. This includes materials used in construction, such as bio-compatible alloys, and designs that reduce the risk of migration or fracture. In addition, improved awareness among healthcare providers about the risks of VTE and the appropriate use of IVCFs has led to increased adoption. Furthermore, advancements in diagnostic techniques have enhanced the detection of DVT, prompting the use of IVCFs as a preventive measure. Also, growing healthcare infrastructure and increasing healthcare expenditure in emerging markets are expanding the market for IVCFs.

Inferior Vena Cava Filters (IVCF) Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on Product Type segmentation, the permanent segment was predicted to show maximum market share in the year 2023, owing to high durability and long-term switching benefits.

Based on Application segmentation, the Venous Thromboembolism segment was the leading Application in 2023, due to rising demand for minimally invasive techniques.

Based on End User segmentation, the hospital segment was the leading End User in 2023, owing to the high prevalence of venous thromboembolism diseases.

On the basis of region, North America was the leading revenue generator in 2023, owing to a high number of patients in VTE.

Inferior Vena Cava Filters (IVCF) Market- Segmentation Analysis:

The Global Inferior Vena Cava Filters (IVCF) Market is segmented on the basis of Product Type, Application, End User, and Region.

The market is divided into two categories based on Product Type: retrievable and permanent. The permanent segment dominates the market. The high adoption of permanent IVCF especially in hospitals is increasing segment growth.

The market is divided into two categories based on Application: venous thromboembolism and pulmonary embolism. The venous thromboembolism segment dominates the market. The rising prevalence of cardiac ailments and other pulmonary diseases is stimulating market growth.

The market is divided into three categories based on End Users: hospitals, ambulatory surgical centers, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The rising demand from hospitals for treatment owing to cardiac and blood clotting disorders are spurring segment growth.

Inferior Vena Cava Filters (IVCF) Market- Geographical Insights

Globally, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. In North America, U.S. and Canada have well-established healthcare systems with high awareness of VTE and its complications. The market is driven by a large patient pool, advanced medical technology, and favorable reimbursement policies. The demand for retrievable IVCFs is significant, reflecting the preference for temporary filters that can be removed once the risk of PE has decreased. Europe is witnessing increasing healthcare spending and improving healthcare facilities, driving the adoption of IVCFs.

Inferior Vena Cava Filters (IVCF) Market- Competitive Landscape:

The market for Inferior Vena Cava Filters (IVCF) is significantly competitive and driven by several key companies that innovate, manufacture, and distribute these medical devices. One of the leading players in the IVCF market, Boston Scientific offers a range of IVCF products. Further, companies in the market continually invest in research and development to improve the design, efficacy, and safety of their products. Technological advancements include enhanced filter designs to reduce complications like migration or fracture, and materials that improve biocompatibility.

Recent Developments:

In December 2022, Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval by the National Medical Products Administration of the People's Republic of China, for their Retrievable IVCF.

In June 2022, Cordis-X invested around USD 11.5 million in Adient Medical, a manufacturer of a next-generation absorbable inferior vena cava (IVC) filter for product development.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFERIOR VENA CAVA FILTERS (IVCF) MARKET KEY PLAYERS

GLOBAL INFERIOR VENA CAVA FILTERS (IVCF) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

GLOBAL INFERIOR VENA CAVA FILTERS (IVCF) MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

GLOBAL INFERIOR VENA CAVA FILTERS (IVCF) MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

GLOBAL INFERIOR VENA CAVA FILTERS (IVCF) MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

Table of Contents

1. Inferior Vena Cava Filters (IVCF) Market Overview

2. Executive Summary

3. Inferior Vena Cava Filters (IVCF) Key Market Trends

4. Inferior Vena Cava Filters (IVCF) Industry Study

5. Inferior Vena Cava Filters (IVCF) Market: COVID-19 Impact Analysis

6. Inferior Vena Cava Filters (IVCF) Market Landscape

7. Inferior Vena Cava Filters (IVCF) Market - By Product Type

8. Inferior Vena Cava Filters (IVCF) Market - By Application

9. Inferior Vena Cava Filters (IVCF) Market - By End User

10. Inferior Vena Cava Filters (IVCF) Market- By Geography

11. Key Vendor Analysis- Inferior Vena Cava Filters (IVCF) Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â